Demise of beta integrin inhibitor
XOMA and Millennium Pharmaceuticals have abandoned the development
of MLN2201, a compound designed to inhibit vascular inflammation.
Nuevolution raises $15m for libraries
Danish company Nuevolution has raised $15 million in order to fund
the continued development of its Chemetic range of focused compound
Liquid handling from KNF
German company KNF Neuberger has announced the UK release of a new
3-in-1 liquid handling device. The company believes it has combined
efficiency with speed in the product that also cuts down on
Erweka launches dissolution tester
Germany's Erweka has introduced a new dissolution testing system
that it says is more accurate and easy to use than rival products.
Amersham soars on takeover bid
After Amersham confirmed yesterday that it had received a bid from
an unnamed suitor wishing to buy the entire company, its shares
rose more than 16 per cent; both J&J and Roche are in the
Nucleic acids on tap
DRI and Tecan UK forge an alliance to use the former's CST reagents
on Tecan's liquid-handling devices. The collaboration will provide
automated nucleic acid purification systems.
Merck Bio launches proteomics tools
Merck Biosciences has introduced a new range of kits for removing
and extracting protein from complex biological samples used in
Alzheimer's diagnostic in the offing?
Scientists at Berlex Pharmaceuticals, the US subsidiary of
Germany's Schering, have identified a biologic marker for
Alzheimer's that could form the basis of a diagnostic test.
Axon has licensed rights to Cellectricon's electroporation
technology to enhance the performance of its Axoporator products,
used to deliver DNA and other large molecules into cells.
More whole genome arrays launched
New microarray products covering the human genome have been
launched by MWG Biotech and Agilent Technologies, adding to the
choice of products available to researchers.
Epoch breaks Amersham deal
Amersham will no longer act as a distributor for Epoch Bioscience's
MGB Eclipse range of probe systems after failing to meet sales
targets, according to the latter company.
Big Blue partners thermo on LIMS
Thermo Electron has teamed up with IBM to launch an offensive on
the LIMS marketplace. The collaboration will focus on LIMS systems
based on IBM's eServer system hardware.
Tiny doses for early trials
Pharmaceutical Profiles and Xceleron have set up a commercial human
microdosing service aimed at reducing failure rates of candidate
drugs at Phase I.
Human Epigenome Project gets going
Epigenomics and the Wellcome Trust Sanger Institute are to press
ahead with the first phase of the Human Epigenome Project following
the successful completion of a pilot study funded by the European
Flamel to raise $62m in share offering
France's Flamel Technologies has started a drive to raise funds in
the USA via a placement of shares aimed at raising $62.1 million,
to be spent on advancing its drug delivery technologies.